The Challenge of CMC Regulatory Compliance for Biopharmaceuticals and Other Biologics

An effective CMC regulatory compliance strategy for biologics and biopharmaceuticals can seem like a mystery. �Through means of this 2nd edition, this no longer needs to occur.� A great deal of thanks goes to two regulatory authorities  the United States Food and Drug Administration (FDA) and the E...

Full description

Bibliographic Details
Main Author: Geigert, John. (Author)
Corporate Author: SpringerLink (Online service)
Format: Electronic
Language:English
Published: New York, NY : Springer New York : Imprint: Springer, 2013.
Edition:2nd ed. 2013.
Subjects:
Online Access:https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4614-6916-2